Bolt Biotherapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
A group of investment entities, including Nan Fung Group and Pivotal bioVenture Partners, have reduced their beneficial ownership in Bolt Biotherapeutics, Inc. to below the 5% threshold.